SCHEMBL591233

SCHEMBL591233

N#Cc1c(C#N)c(O)c2c([N+](=O)[O-])cccc2c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.50
▸ GPR35 Q9HC97 2/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ GAA P10253 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ CACNA1B Q00975 1/20 0.50
▸ APBA1 Q02410 1/20 0.50
▸ TDP1 Q9NUW8 2/20 0.47
▸ ERN1 O75460 1/20 0.41
▸ CASP6 P55212 1/20 0.41
▸ CTSB P07858 4/20 0.40
▸ HPGD P15428 1/20 0.38
▸ IDO1 P14902 1/20 0.38
▸ TDO2 P48775 1/20 0.38
▸ S100A4 P26447 1/20 0.38
▸ CDK2 P24941 1/20 0.37
▸ APAF1 O14727 1/20 0.37
▸ ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30499573 1.00 ALDH1A1 (0.50) ALDH1A1GPR35KDM4EMEN1GAA
SCHEMBL17603289 0.78 GPR35 (0.59) ALDH1A1GPR35KDM4EMEN1GAA
SCHEMBL9794635 0.77 CTSB (0.46) ALDH1A1GPR35KDM4EMEN1GAA
SCHEMBL618153 0.75 TDP1 (0.54) ALDH1A1GPR35MEN1KMT2ATDP1
SCHEMBL621936 0.75 GPR35 (0.56) ALDH1A1GPR35KDM4EMAPTTDP1
SCHEMBL32691850 0.71 GPR35 (0.64) ALDH1A1GPR35MEN1MAPTKMT2A
SCHEMBL14560963 0.71 ALDH1A1 (0.59) ALDH1A1KDM4EMEN1GAAMAPT
SCHEMBL16959740 0.71 TDP1 (0.45) ALDH1A1GPR35MAPTTDP1HPGD
SCHEMBL1344484 0.71 GPR35 (0.64) ALDH1A1GPR35MEN1MAPTKMT2A
SCHEMBL28027350 0.71 TDP1 (0.73) ALDH1A1GPR35KDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12163968-B2 Preparation of nucleated RBC (NRBC) analogs for use as reference hematology controls in automated hematology analyzers BIO-RAD LABORATORIES, INC. (US) 2024-12-10 — — US claimed
US-12163968-B2 Preparation of nucleated RBC (NRBC) analogs for use as reference hematology controls in automated hematology analyzers BIO-RAD LABORATORIES, INC. (US) 2024-12-10 — — US disclosed
EP-4208021-A1 PREPARATION OF NUCLEATED RBC (NRBC) ANALOGS FOR USE AS REFERENCE HEMATOLOGY CONTROLS IN AUTOMATED HEMATOLOGY ANALYZERS Bio-Rad Laboratories, Inc. (US) 2023-07-12 — — EP disclosed
CN-116097093-A Preparation of Nucleated RBC (NRBC) analogs for use as reference blood controls in automated blood analyzers 生物辐射实验室股份有限公司 2023-05-09 — — CN disclosed
WO-2022051443-A1 PREPARATION OF NUCLEATED RBC (NRBC) ANALOGS FOR USE AS REFERENCE HEMATOLOGY CONTROLS IN AUTOMATED HEMATOLOGY ANALYZERS BIO-RAD LABORATORIES, INC. (US) 2022-03-10 — — WO disclosed
US-20220065878-A1 PREPARATION OF NUCLEATED RBC (NRBC) ANALOGS FOR USE AS REFERENCE HEMATOLOGY CONTROLS IN AUTOMATED HEMATOLOGY ANALYZERS BIO-RAD LABORATORIES, INC. 2022-03-03 — — US disclosed
US-20210395487-A1 COLORING COMPOSITION, FILM, COLOR FILTER, SOLID-STATE IMAGING ELEMENT, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2021-12-23 — — US disclosed
US-20180208775-A1 NEW AROMATIC MACROCYCLIC METAL COMPLEX DYES AND THE SYNTHESIS THEREOF WITH ACTIVE NANO METAL POWDERS OLGUN UGURSOY (TR) 2018-07-26 — — US disclosed
EP-3157927-A1 NEW AROMATIC MACROCYCLIC METAL COMPLEX DYES AND THE SYNTHESIS THEREOF WITH ACTIVE NANO METAL POWDERS Olgun, Ugursoy (TR) 2017-04-26 — — EP disclosed
WO-2015199628-A1 NEW AROMATIC MACROCYCLIC METAL COMPLEX DYES AND THE SYNTHESIS THEREOF WITH ACTIVE NANO METAL POWDERS OLGUN UĞURSOY (TR) 2015-12-30 — — WO disclosed
EP-2376908-B1 SIMULATION OF NORMAL FRESH BLOOD PLATELETS BIO RAD LABORATORIES (US) 2014-12-31 — — EP disclosed
US-8114580-B2 Simulation of normal fresh blood platelets for reference control BIO-RAD LABORATORIES, INC. (US) 2012-02-14 — — US disclosed
CN-102341701-A Mimetics of normal fresh platelets BIO RAD LABORATORIES 2012-02-01 — — CN disclosed
EP-2376908-A1 SIMULATION OF NORMAL FRESH BLOOD PLATELETS Bio-Rad Laboratories, Inc. (US) 2011-10-19 — — EP disclosed
WO-2010083130-A1 SIMULATION OF NORMAL FRESH BLOOD PLATELETS BIO-RAD LABORATORIES, INC. (US) 2010-07-22 — — WO disclosed
US-20100178647-A1 SIMULATION OF NORMAL FRESH BLOOD PLATELETS BIO-RAD LABORATORIES, INC. (US) 2010-07-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100178647-A1 SIMULATION OF NORMAL FRESH BLOOD PLATELETS MPL, THPO, PFKP ALDH1A1 4005/4885GPR35 2224/4885KDM4E 3264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback